Thursday 06 Jun 2013
Defence and security group Ultra Electronics has acquired specialist computing expert Varisys for up to 18m pounds cash.
Thursday 06 Jun 2013
easyJet flew more passengers on filled more seats on planes in May, according to the budget airline's traffic statistics released on Thursday morning.
Thursday 06 Jun 2013
Speciality chemicals company Johnson Matthey reported weaker annual results, in what it described as a challenging year, but said it remains well positioned to grow its business over the medium and long term.
Thursday 06 Jun 2013
A round-up of the biggest director buys today so far.
Wednesday 05 Jun 2013
London was dragged lower by Wall Street on Wednesday. Somewhat ironically, that came on the same day as a better than expected reading on UK services, courtesy of market compiler Markit, led some observers to confidently predict that incoming Bank of England Governor Mark Carney may no longer have as much of a need to ‘think outside of the box,’ as regards the monetary policy needed by the UK.
Wednesday 05 Jun 2013
It was another volatile morning for financial markets on Wednesday as ongoing worries about stimulus measures in the US and a heavy economic data schedule dominated market sentiment.
Wednesday 05 Jun 2013
Bank of America Merrill Lynch (BofA) reiterated its 'buy' rating and 1,372p target price for chip designer ARM Holdings on Wednesday morning, following a confident presentation from the company at the bank's global tech conference.
Wednesday 05 Jun 2013
The UK’s service sector expanded in May as new business rose at its fastest rate in more than three years, according to new data Friday.
Wednesday 05 Jun 2013
Crude oil futures ended Tuesday's session a touch lower with many investors refraining from bids ahead of US weekly crude oil inventories.
Wednesday 05 Jun 2013
Intermediate Capital Group (ICG), the FTSE 250-listed asset manager, is to close its real-estate debt fund ICG-Longbow Fund III at its maximum size of 700m pounds.
Wednesday 05 Jun 2013
MoneySupermarket.com underlined its confidence in future trading as it announced it would pay a special interim dividend.
Wednesday 05 Jun 2013
Engineering and construction group Kentz Corporation has landed a contract in Alaska for the Point Thomson gas cycling and condensate production plant.
Wednesday 05 Jun 2013
Financial Times reports that tech giant Apple is facing an import ban in the US on certain models of its iPhone 4 and iPad 2 (as well as some older devices) after the International Trade Commission said that the devices infringed Samsung's patents.
Tuesday 04 Jun 2013
Speculation surrounding the future of the Federal Reserve’s stimulus programme continued to drive market sentiment on Tuesday as stocks rebounded on hopes that the US central bank will delay scaling back measures as it awaits a firmer recovery.
Tuesday 04 Jun 2013
Hopes that the US Federal Reserve would delay pulling the plug on stimulus and a surprise return to growth in the UK construction sector gave markets a boost on Tuesday morning, with the FTSE 100 rebounding from a one-month low the day before.
Tuesday 04 Jun 2013
Glencore Xstrata’s copper mines in Peru are being eyed off by two companies linked to Chinese state-backed groups, Reuters reported Tuesday.
Tuesday 04 Jun 2013
Biopharmaceuticals giant AstraZeneca will be hit by a one-off impairment charge after admitting that it has decided not to pursue a regulatory filing for fostamatinib, an oral drug it was hoping could be an alternative treatment for rheumatoid arthritis.
Tuesday 04 Jun 2013
Shares in FTSE 250-listed defence and security technology group Cobham were down early on Tuesday morning after a Bloomberg news report claimed that one of Cobham's institutional investors would be selling 39.1m shares.
Tuesday 04 Jun 2013
Primark has launched its first online venture with the sale of a range of 20 garments through internet fashion retailer Asos.
Tuesday 04 Jun 2013
Panmure Gordon has retained its 'hold' rating and 3,200p target price for biopharmaceuticals group AstraZeneca, saying that the news of the pull-out from fostamatinib should remind investors of the risks that the business carries.
You are here: news > editors picks